mRNA Cancer Vaccines And Therapeutics Market Trends 2025–2029: Forecasts for Key Growth Segments
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Does The Market Size Of The mRNA Cancer Vaccines And Therapeutics Industry Compare Between 2025 And 2029?
The mRNA cancer vaccines and therapeutics market has seen rapid expansion in recent years. This market is expected to expand from $61.52 billion in 2024 to $71.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.8%. The historical increase can be ascribed to evolving lifestyles, robust funding support, a conducive regulatory framework, an established healthcare infrastructure, and a rise in pipeline development.
The market for mRNA cancer vaccines and therapeutics is projected to experience swift expansion over the coming years. This market is anticipated to reach a valuation of $125.56 billion by 2029, achieving a compound annual growth rate (CAGR) of 15.2%. The increase during the forecast period stems from factors such as encouraging clinical trial outcomes, increasing understanding and adoption of mRNA technology, existing unmet medical demands in cancer therapy, the promise of better patient results, and the possibility of readily available, off-the-shelf products. Significant trends expected in this period encompass broadening into novel therapeutic domains, adopting a personalized medicine strategy, innovations in mRNA delivery mechanisms, the development of multivalent mRNA vaccines, and the integration of artificial intelligence and machine learning into mRNA design processes.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17204&type=smp
Which Factors And Drivers Are Influencing The mRNA Cancer Vaccines And Therapeutics Market In 2025?
The increasing incidence of cancer is projected to stimulate expansion in the mRNA cancer vaccine and therapeutic market in the future. Cancer broadly refers to a collection of illnesses marked by the uncontrolled multiplication and dissemination of atypical cells, which infiltrate and harm healthy bodily tissue. This increase in cancer prevalence stems from inactive lifestyles, poor dietary choices, and exposure to environmental pollutants. mRNA cancer vaccines and therapies are essential for cancer as they provide customized, precise treatments capable of bolstering the immune system’s capacity to identify and combat cancer cells, thereby boosting treatment effectiveness and patient results. For example, data released in January 2023 by the American Cancer Society, a US-based non-profit dedicated to eradicating cancer, indicated that the estimated new cancer cases in the United States were approximately 1,918,030 in 2022, rising to 1,958,310 in 2023. Breast cancer stands as the primary chronic ailment in the United States, with cases growing from 287,850 in 2022 to 297,790 in 2023. Consequently, the escalating prevalence of cancer is a key factor propelling the expansion of the mRNA cancer vaccine and therapeutics market.
What Are The Key Segments In The mRNA Cancer Vaccines And Therapeutics Market?
The mrna cancer vaccines and therapeutics market covered in this report is segmented –
1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas
2) By Application: Infectious Disease, Cancer, Other Applications
3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users
Subsegments:
1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas
2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer
3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma
What Trends Are Expected To Drive The mRNA Cancer Vaccines And Therapeutics Market?
Prominent entities within the mRNA cancer vaccine and therapeutics market are prioritizing the creation of advanced therapies, specifically mRNA cancer vaccines, aiming to boost effectiveness, better patient results, and cater to the rising need for successful cancer treatments. mRNA cancer vaccines function as a form of immunotherapy leveraging messenger RNA to direct cells in producing target antigens, consequently prompting the immune system to identify and target malignant cells. For instance, in May 2024, WestGene Biopharma, a China-based biotechnology firm, secured FDA clearance for an investigational new drug application concerning its mRNA therapeutic cancer vaccine, WGc-043. The FDA’s approval of WGc-043 signifies a significant breakthrough in managing advanced EB virus-related cancers, which are closely associated with more than ten distinct malignancies, encompassing nasopharyngeal carcinoma, NK T-cell lymphoma, and gastric, lung, liver, esophageal, breast, and cervical cancers, as well as autoimmune conditions such as multiple sclerosis and lupus.
Which Industry Leaders Are Driving Innovation Across The mRNA Cancer Vaccines And Therapeutics Market?
Major companies operating in the mRNA cancer vaccines and therapeutics market are Pfizer Inc., Merck & Co Inc., Bayer AG, Novartis SA, Sanofi AG, AstraZeneca Plc, GlaxoSmithKline Plc, Hoffmann-La Roche AG, Eli Lilly and Company, Moderna Therapeutics Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac N.V, Anima Biotech, Argos Therapeutics Inc.
Download The Full Report For Exclusive Market Findings:
Which Global Regions Are Influencing The Competitive Landscape Of The mRNA Cancer Vaccines And Therapeutics Market?
North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA cancer vaccines and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The mRNA Cancer Vaccines And Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=17204&type=smp
Browse Through More Reports Similar to the Global mRNA Cancer Vaccines And Therapeutics Market 2025, By The Business Research Company
Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Global Market Report 2025
Cancer Biologics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report
Skin Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
